Gaudium IVF & Women Health Ltd
Listed
NSE & BSE
Mainboard
Live Chart
| Category | Subscription | Shares Offered | % of Total | Amount (₹Cr) |
|---|---|---|---|---|
|
QIB
|
Over 1.00x
|
10,443,100
50% |
50%
|
₹82.50 |
|
NII / HNI
|
Over 1.00x
|
3,132,930
15% |
15%
|
₹24.75 |
|
Retail
|
Over 1.00x
|
7,310,170
35% |
35%
|
₹57.75 |
| Total | 1.00x | 20,886,200 |
100% | ₹165.00 |
| Category | Shares Offered | Amount (₹Cr) | Size (%) |
|---|---|---|---|
| QIB | 10,443,100 | ₹82.50 |
50.00%
|
| NII | 3,132,930 | ₹24.75 |
15.00%
|
| Retail | 7,310,170 | ₹57.75 |
35.00%
|
| Total | 20,886,200 | ₹165.00 |
100.00%
|
| QIB | NII | Retail | Total | |||||
|---|---|---|---|---|---|---|---|---|
| Ex. Anchor | Anchor | Total QIB | Below ₹10L | Above ₹10L | Total NII | |||
| Allocation (shares) | — | — | — | — | — | 3,132,930 | 7,310,170 | 10,443,100 |
| Allotment price (₹) | 79 | 79 | 79 | 79 | 79 | 79 | 79 | 79 |
| No. of applications | — | — | — | — | — | — | — | — |
| No. of shares applied | — | — | — | — | — | — | — | — |
| Amount collected (₹Cr) | — | — | — | — | — | — | ₹57.75 | ₹57.75 |
| Times subscribed | 1 | — | — | — | — | 1 | 1 | 1 |
| Shares allotted | — | — | — | — | — | 3,132,930 | 7,310,170 | 10,443,100 |
| No. of allottees | — | — | — | — | — | — | — | — |
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min — 2 Lots) | 2 | 378 | ₹29,862 |
| Retail (Max — 13 Lots) | 13 | 2,457 | ₹194,103 |
| S-HNI (Min — 14 Lots) | 14 | 2,646 | ₹209,034 |
| B-HNI (Min — 68 Lots) | 68 | 12,852 | ₹1,015,308 |
Gaudium IVF & Women Health Ltd is proposing an IPO on NSE & BSE under the Mainboard category. Total issue: 2,08,86,200 shares (agg. up to ₹[.] Cr).
Opens 20 Feb 2026, closes 24 Feb 2026. Listing: 27 Feb 2026. Apply via ASBA or UPI.
| Particulars | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Revenue from Operations | 49.75 | 70.96 | 48.15 |
| EBITDA | 18.95 | 28.63 | 19.27 |
| Profit After Tax (PAT) | 12.51 | 19.13 | 10.32 |
| Net Worth | 58.85 | 46.30 | 26.99 |
| Total Assets | 106.62 | 88.51 | 51.01 |
| Reserves & Surplus | 28.16 | 15.60 | 26.00 |
| Borrowings | 22.51 | 18.93 | 15.73 |
| EBITDA Margin (%) | 38.29% | — | — |
| PAT Margin (%) | 25.14% | — | — |
Gaudium IVF & Women Health Ltd IPO is subscribed 1.00 times by Feb 24, 2026. Retail: 1.00x. QIB: 1.00x. NII: 1.00x.
| Investor Category | Subscription |
|---|---|
| Qualified Institutional (QIB) | 1.00x |
| Non Institutional (NII/HNI) | 1.00x |
| Retail Individual | 1.00x |
| Total Subscription | 1.00x |
The Gaudium IVF & Women Health Ltd IPO retail category is subscribed 1.00 times as of 24 Feb 2026. The retail portion is oversubscribed.
Subscribe via your broker app using ASBA or UPI. Opens 20 Feb 2026 and closes 24 Feb 2026. Min investment: ₹14,931 (1 lot = 189 shares). UPI mandate: 5:00 PM on 24 Feb 2026.
The Gaudium IVF & Women Health Ltd IPO subscribed 1.00x overall. QIB: 1.00x, NII: 1.00x, Retail: 1.00x. Applications: from NSE/BSE.
Check allotment on the registrar website. Enter your PAN, application number or DP/Client ID. Allotment date: 02 Mar 2026. Refunds: on 03 Mar 2026.
The Gaudium IVF & Women Health Ltd IPO listing date is 27 Feb 2026, Friday. Listed on: NSE & BSE. Issue price: ₹79. Estimated listing: ₹91. GMP: +₹12.
The Gaudium IVF & Women Health Ltd IPO closes on 24 Feb 2026, Tuesday. UPI mandate: 5:00 PM on 24 Feb 2026. Allotment: 02 Mar 2026. Listing: 27 Feb 2026.